94224-3

LOINC 2.82

RET gene full mutation analysis in Blood or Tissue by Sequencing

RET gene Full Mut Anl Bld/T Seq

Definition

  • Testing includes full sequencing of the RET gene, including all exons 1-20, to identify pathogenic or likely pathogenic mutations associated with various conditions, including multiple endocrine neoplasia type A or B, Hirschsprung disease, or congenital central hypoventilation syndrome.[GHR gene:RET]

Component

  • RET gene full mutation analysis

Specimen / system

  • Bld/Tiss

Class

  • MOLPATH

Property

  • Find

Scale

  • Doc

Method

  • Sequencing

Related names

  • Blood; CDHF12; CDHR16; C-RET; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HSCR1; HTS; Inherited; MEN2A; MEN2B; Molecular pathology; MOLPATH; MTC1; Multiple endocrine neoplasia type IIa; Multiple endocrine neoplasia type IIb; Mut; Mutations; Next generation sequencing; NGS; Point in time; PTC; Random; ret proto-oncogene; RET51; RET-ELE1; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Index terms

  • Blood
  • C-RET
  • CDHF12
  • CDHR16
  • Document
  • Finding
  • Findings
  • full gene sequencing
  • Full Mut Anl
  • Genetics
  • Heredity
  • Heritable
  • high-throughput sequencing
  • HSCR1
  • HTS
  • Inherited
  • MEN2A
  • MEN2B
  • Molecular pathology
  • MOLPATH
  • MTC1
  • Multiple endocrine neoplasia type IIa
  • Multiple endocrine neoplasia type IIb
  • Mut
  • Mutations
  • Next generation sequencing
  • NGS
  • Point in time
  • PTC
  • Random
  • ret proto-oncogene
  • RET-ELE1
  • RET51
  • sequencing of entire coding region
  • Tissue
  • Tissue, unspecified
  • WB
  • Whole blood
  • Whole blood or Tissue